SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-023516
Filing Date
2024-06-11
Accepted
2024-06-11 17:53:48
Documents
1
Period of Report
2024-06-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3301
  Complete submission text file 0001493152-24-023516.txt   4799
Mailing Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123
Business Address 4995 MURPHY CANYON ROAD, SUITE 300 SAN DIEGO CA 92123 (760) 471 8536
CONDUIT PHARMACEUTICALS INC. (Issuer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 38 OXBERRY AVENUE LONDON X0 SW6 5SS
Business Address
Bligh James (Reporting) CIK: 0001990748 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41245 | Film No.: 241036971